Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred Frank currently holds 74,327 shares of EPIX Pharmaceuticals, Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Frank has been a net seller of EPIX stock. They have purchased $0 and sold $19.9M worth of shares.
Fred Frank's most recent insider trade was on Oct 14, 2020, when they sold 8,303 shares at $10.42 per share.
Fred Frank serves as Executive at EPIX Pharmaceuticals, Inc. (EPIX). They have executed 336 insider transactions totaling $19.9M over their tenure at the company.
Fred Frank holds the position of Executive at EPIX Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Fred Frank has shown a selling trading pattern, with $0 in total purchases and $19.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fred Frank was on Aug 8, 2014, when they sold $364.8K worth of LNDC shares. This transaction involved 30,000 shares at $12.16 per share.
Fred Frank currently owns 74,327 shares of EPIX Pharmaceuticals, Inc. (EPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred Frank's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred Frank has 336 Form 4 filings on record as an insider at EPIX Pharmaceuticals, Inc..
Set alerts for Fred Frank and 40,000+ other insiders.